Skip to main content
Top
Published in: BMC Cancer 1/2017

Open Access 01-12-2017 | Research article

Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study

Authors: Huan Song, Fang Fang, Unnur Valdimarsdóttir, Donghao Lu, Therese M.-L. Andersson, Christina Hultman, Weimin Ye, Lars Lundell, Jan Johansson, Magnus Nilsson, Mats Lindblad

Published in: BMC Cancer | Issue 1/2017

Login to get access

Abstract

Background

Except for overall survival, whether or not waiting time for treatment could influences other domains of cancer patients’ overall well-being is to a large extent unknown. Therefore, we performed this study to determine the effect of waiting time for cancer treatment on the mental health of patients with esophageal or gastric cancer.

Methods

Based on the Swedish National Quality Register for Esophageal and Gastric Cancers (NREV), we followed 7,080 patients diagnosed 2006–2012 from the time of treatment decision. Waiting time for treatment was defined as the interval between diagnosis and treatment decision, and was classified into quartiles. Mental disorders were identified by either clinical diagnosis through hospital visit or prescription of psychiatric medications. For patients without any mental disorder before treatment, the association between waiting time and subsequent onset of mental disorders was assessed by hazard ratios (HRs) with 95% confidence interval (CI), derived from multivariable-adjusted Cox model. For patients with a preexisting mental disorder, we compared the rate of psychiatric care by different waiting times, allowing for repeated events.

Results

Among 4,120 patients without any preexisting mental disorder, lower risk of new onset mental disorders was noted for patients with longer waiting times, i.e. 18–29 days (HR 0.86; 95% CI 0.74-1.00) and 30–60 days (HR 0.79; 95% CI 0.67-0.93) as compared with 9–17 days. Among 2,312 patients with preexisting mental disorders, longer waiting time was associated with more frequent psychiatric hospital care during the first year after treatment (37.5% higher rate per quartile increase in waiting time; p for trend = 0.0002). However, no such association was observed beyond one year nor for the prescription of psychiatric medications.

Conclusions

These data suggest that waiting time to treatment for esophageal or gastric cancer may have different mental health consequences for patients depending on their past psychiatric vulnerabilities. Our study sheds further light on the complexity of waiting time management, and calls for a comprehensive strategy that takes into account different domains of patient well-being in addition to the overall survival.
Appendix
Available only for authorised users
Literature
1.
go back to reference Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17(12):3077–9.CrossRefPubMed Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17(12):3077–9.CrossRefPubMed
2.
go back to reference Rice TW, Blackstone EH, Rusch VW. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol. 2010;17(7):1721–4.CrossRefPubMed Rice TW, Blackstone EH, Rusch VW. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol. 2010;17(7):1721–4.CrossRefPubMed
3.
go back to reference Matsuo K, Opper NR, Ciccone MA, Garcia J, Tierney KE, Baba T, Muderspach LI, Roman LD. Time interval between endometrial biopsy and surgical staging for type I endometrial cancer association between tumor characteristics and survival outcome. Obstet Gynecol. 2015;125(2):424–33.CrossRefPubMed Matsuo K, Opper NR, Ciccone MA, Garcia J, Tierney KE, Baba T, Muderspach LI, Roman LD. Time interval between endometrial biopsy and surgical staging for type I endometrial cancer association between tumor characteristics and survival outcome. Obstet Gynecol. 2015;125(2):424–33.CrossRefPubMed
4.
go back to reference Comber H, Cronin DP, Deady S, Lorcain PO, Riordan P. Delays in treatment in the cancer services: impact on cancer stage and survival. Ir Med J. 2005;98(8):238–9.PubMed Comber H, Cronin DP, Deady S, Lorcain PO, Riordan P. Delays in treatment in the cancer services: impact on cancer stage and survival. Ir Med J. 2005;98(8):238–9.PubMed
5.
go back to reference Department of Health. The NHS cancer plan. Department of Health, London; 2000. Department of Health. The NHS cancer plan. Department of Health, London; 2000.
6.
go back to reference Raptis DA, Fessas C, Belasyse-Smith P, Kurzawinski TR. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer. Surgeon. 2010;8(5):239–46.CrossRefPubMed Raptis DA, Fessas C, Belasyse-Smith P, Kurzawinski TR. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer. Surgeon. 2010;8(5):239–46.CrossRefPubMed
7.
go back to reference Spahos T, Hindmarsh A, Cameron E, Tighe MR, Igali L, Pearson D, Rhodes M, Lewis MP. Endoscopy waiting times and impact of the two week wait scheme on diagnosis and outcome of upper gastrointestinal cancer. Postgrad Med J. 2005;81(961):728–30.CrossRefPubMedPubMedCentral Spahos T, Hindmarsh A, Cameron E, Tighe MR, Igali L, Pearson D, Rhodes M, Lewis MP. Endoscopy waiting times and impact of the two week wait scheme on diagnosis and outcome of upper gastrointestinal cancer. Postgrad Med J. 2005;81(961):728–30.CrossRefPubMedPubMedCentral
8.
go back to reference Sharpe D, Williams RN, Ubhi SS, Sutton CD, Bowrey DJ. The “two-week wait” referral pathway allows prompt treatment but does not improve outcome for patients with oesophago-gastric cancer. Eur J Surg Oncol. 2010;36(10):977–81.CrossRefPubMed Sharpe D, Williams RN, Ubhi SS, Sutton CD, Bowrey DJ. The “two-week wait” referral pathway allows prompt treatment but does not improve outcome for patients with oesophago-gastric cancer. Eur J Surg Oncol. 2010;36(10):977–81.CrossRefPubMed
9.
go back to reference Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, Meader N. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160–74.CrossRefPubMed Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, Meader N. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160–74.CrossRefPubMed
10.
go back to reference Lu D, Andersson TM, Fall K, Hultman CM, Czene K, Valdimarsdottir U, Fang F. Clinical Diagnosis of Mental Disorders Immediately Before and After Cancer Diagnosis: A Nationwide Matched Cohort Study in Sweden. JAMA Oncol. 2016;2(9):1188–96. Lu D, Andersson TM, Fall K, Hultman CM, Czene K, Valdimarsdottir U, Fang F. Clinical Diagnosis of Mental Disorders Immediately Before and After Cancer Diagnosis: A Nationwide Matched Cohort Study in Sweden. JAMA Oncol. 2016;2(9):1188–96.
11.
go back to reference Stitzenberg KB, Sigurdson ER, Egleston BL, Starkey RB, Meropol NJ. Centralization of cancer surgery: implications for patient access to optimal care. J Clin Oncol. 2009;27(28):4671–8.CrossRefPubMedPubMedCentral Stitzenberg KB, Sigurdson ER, Egleston BL, Starkey RB, Meropol NJ. Centralization of cancer surgery: implications for patient access to optimal care. J Clin Oncol. 2009;27(28):4671–8.CrossRefPubMedPubMedCentral
12.
go back to reference Bilimoria KY, Ko CY, Tomlinson JS, Stewart AK, Talamonti MS, Hynes DL, Winchester DP, Bentrem DJ. Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg. 2011;253(4):779–85.CrossRefPubMed Bilimoria KY, Ko CY, Tomlinson JS, Stewart AK, Talamonti MS, Hynes DL, Winchester DP, Bentrem DJ. Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg. 2011;253(4):779–85.CrossRefPubMed
13.
go back to reference Liederbach E, Sisco M, Wang C, Pesce C, Sharpe S, Winchester DJ, Yao K. Wait times for breast surgical operations, 2003–2011: a report from the National Cancer Data Base. Ann Surg Oncol. 2015;22(3):899–907.CrossRefPubMed Liederbach E, Sisco M, Wang C, Pesce C, Sharpe S, Winchester DJ, Yao K. Wait times for breast surgical operations, 2003–2011: a report from the National Cancer Data Base. Ann Surg Oncol. 2015;22(3):899–907.CrossRefPubMed
14.
go back to reference Linder G, Lindblad M, Djerf P, Elbe P, Johansson J, Lundell L, Hedberg J. Validation of data quality in the Swedish National Register for Oesophageal and Gastric Cancer. Br J Surg. 2016;103(10):1326–35.CrossRefPubMed Linder G, Lindblad M, Djerf P, Elbe P, Johansson J, Lundell L, Hedberg J. Validation of data quality in the Swedish National Register for Oesophageal and Gastric Cancer. Br J Surg. 2016;103(10):1326–35.CrossRefPubMed
15.
go back to reference Guo Z, Gill TM, Allore HG. Modeling repeated time-to-event health conditions with discontinuous risk intervals. An example of a longitudinal study of functional disability among older persons. Methods Inf Med. 2008;47(2):107–16.PubMedPubMedCentral Guo Z, Gill TM, Allore HG. Modeling repeated time-to-event health conditions with discontinuous risk intervals. An example of a longitudinal study of functional disability among older persons. Methods Inf Med. 2008;47(2):107–16.PubMedPubMedCentral
16.
go back to reference Visser E, Leeftink AG, van Rossum PS, Siesling S, van Hillegersberg R, Ruurda JP. Waiting Time from Diagnosis to Treatment has no Impact on Survival in Patients with Esophageal Cancer. Ann Surg Oncol. 2016;23(8):2679–89. Visser E, Leeftink AG, van Rossum PS, Siesling S, van Hillegersberg R, Ruurda JP. Waiting Time from Diagnosis to Treatment has no Impact on Survival in Patients with Esophageal Cancer. Ann Surg Oncol. 2016;23(8):2679–89.
17.
go back to reference Fassbender K, Walter S, Liu Y, Muehlhauser F, Ragoschke A, Kuehl S, Mielke O. “Mobile stroke unit” for hyperacute stroke treatment. Stroke. 2003;34(6):e44.CrossRefPubMed Fassbender K, Walter S, Liu Y, Muehlhauser F, Ragoschke A, Kuehl S, Mielke O. “Mobile stroke unit” for hyperacute stroke treatment. Stroke. 2003;34(6):e44.CrossRefPubMed
18.
go back to reference Raghavan R, Benzaquen BS, Rudski L. Timing of bypass surgery in stable patients after acute myocardial infarction. Can J Cardiol. 2007;23(12):976–82.CrossRefPubMedPubMedCentral Raghavan R, Benzaquen BS, Rudski L. Timing of bypass surgery in stable patients after acute myocardial infarction. Can J Cardiol. 2007;23(12):976–82.CrossRefPubMedPubMedCentral
19.
go back to reference Helewa RM, Turner D, Park J, Wirtzfeld D, Czaykowski P, Hochman D, Singh H, Shu E, Mckay A. Longer waiting times for patients undergoing colorectal cancer surgery are not associated with decreased survival. J Surg Oncol. 2013;108(6):378–84.CrossRefPubMed Helewa RM, Turner D, Park J, Wirtzfeld D, Czaykowski P, Hochman D, Singh H, Shu E, Mckay A. Longer waiting times for patients undergoing colorectal cancer surgery are not associated with decreased survival. J Surg Oncol. 2013;108(6):378–84.CrossRefPubMed
20.
go back to reference Coughlin S, Plourde M, Guidolin K, Fortin D, Frechette E, Malthaner R, Inculet R. Is it safe to wait? The effect of surgical wait time on survival in patients with non-small cell lung cancer. Can J Surg. 2015;58(6):414–8.CrossRefPubMedPubMedCentral Coughlin S, Plourde M, Guidolin K, Fortin D, Frechette E, Malthaner R, Inculet R. Is it safe to wait? The effect of surgical wait time on survival in patients with non-small cell lung cancer. Can J Surg. 2015;58(6):414–8.CrossRefPubMedPubMedCentral
21.
go back to reference Sanjeevi S, Ivanics T, Lundell L, Kartalis N, Andren-Sandberg A, Blomberg J, Del Chiaro M, Ansorge C. Impact of delay between imaging and treatment in patients with potentially curable pancreatic cancer. Br J Surg. 2016;103(3):267–75.CrossRefPubMed Sanjeevi S, Ivanics T, Lundell L, Kartalis N, Andren-Sandberg A, Blomberg J, Del Chiaro M, Ansorge C. Impact of delay between imaging and treatment in patients with potentially curable pancreatic cancer. Br J Surg. 2016;103(3):267–75.CrossRefPubMed
22.
go back to reference Bleicher RJ, Ruth K, Sigurdson ER, Beck JR, Ross E, Wong YN, Patel SA, Boraas M, Chang EI, Topham NS, et al. Time to surgery and breast cancer survival in the united states. JAMA Oncol. 2016;2(3):330–9.CrossRefPubMed Bleicher RJ, Ruth K, Sigurdson ER, Beck JR, Ross E, Wong YN, Patel SA, Boraas M, Chang EI, Topham NS, et al. Time to surgery and breast cancer survival in the united states. JAMA Oncol. 2016;2(3):330–9.CrossRefPubMed
23.
go back to reference van Harten MC, Hoebers FJ, Kross KW, van Werkhoven ED, van den Brekel MW, van Dijk BA. Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival. Oral Oncol. 2015;51(3):272–8.CrossRefPubMed van Harten MC, Hoebers FJ, Kross KW, van Werkhoven ED, van den Brekel MW, van Dijk BA. Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival. Oral Oncol. 2015;51(3):272–8.CrossRefPubMed
24.
go back to reference Murphy CT, Galloway TJ, Handorf EA, Egleston BL, Wang LS, Mehra R, Flieder DB, Ridge JA. Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United States. J Clin Oncol. 2016;34(2):169–78.CrossRefPubMed Murphy CT, Galloway TJ, Handorf EA, Egleston BL, Wang LS, Mehra R, Flieder DB, Ridge JA. Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United States. J Clin Oncol. 2016;34(2):169–78.CrossRefPubMed
25.
go back to reference Elit LM, O’Leary EM, Pond GR, Seow HY. Impact of wait times on survival for women with uterine cancer. J Clin Oncol. 2014;32(1):27–33.CrossRefPubMed Elit LM, O’Leary EM, Pond GR, Seow HY. Impact of wait times on survival for women with uterine cancer. J Clin Oncol. 2014;32(1):27–33.CrossRefPubMed
26.
go back to reference Drageset S, Lindstrom TC, Giske T, Underlid K. Being in suspense: women’s experiences awaiting breast cancer surgery. J Adv Nurs. 2011;67(9):1941–51.CrossRefPubMed Drageset S, Lindstrom TC, Giske T, Underlid K. Being in suspense: women’s experiences awaiting breast cancer surgery. J Adv Nurs. 2011;67(9):1941–51.CrossRefPubMed
27.
go back to reference Lally RM. Acclimating to breast cancer a process of maintaining self-integrity in the pretreatment period. Cancer Nurs. 2010;33(4):268–79.CrossRefPubMed Lally RM. Acclimating to breast cancer a process of maintaining self-integrity in the pretreatment period. Cancer Nurs. 2010;33(4):268–79.CrossRefPubMed
28.
go back to reference Henselmans I, Sanderman R, Smink A, Ranchor AV, de Vries J. Waiting times in breast disease clinics and psychological well-being: speedy care is better care. Ned Tijdschr Geneeskd. 2010;154:B491.PubMed Henselmans I, Sanderman R, Smink A, Ranchor AV, de Vries J. Waiting times in breast disease clinics and psychological well-being: speedy care is better care. Ned Tijdschr Geneeskd. 2010;154:B491.PubMed
29.
go back to reference McConnell YJ, Inglis K, Porter GA. Timely access and quality of care in colorectal cancer: are they related? Int J Qual Health Care. 2010;22(3):219–28.CrossRefPubMed McConnell YJ, Inglis K, Porter GA. Timely access and quality of care in colorectal cancer: are they related? Int J Qual Health Care. 2010;22(3):219–28.CrossRefPubMed
30.
go back to reference Porter G, Urquhart R, Kendell C, Bu J, McConnell Y, Grunfeld E. Timely access and quality of care in colorectal cancer: a population-based cohort study using administrative data. BMC Res Notes. 2013;6:355.CrossRefPubMedPubMedCentral Porter G, Urquhart R, Kendell C, Bu J, McConnell Y, Grunfeld E. Timely access and quality of care in colorectal cancer: a population-based cohort study using administrative data. BMC Res Notes. 2013;6:355.CrossRefPubMedPubMedCentral
31.
go back to reference Guan NC, Termorshuizen F, Laan W, Smeets HM, Zainal NZ, Kahn RS, De Wit NJ, Boks MP. Cancer mortality in patients with psychiatric diagnoses: a higher hazard of cancer death does not lead to a higher cumulative risk of dying from cancer. Soc Psychiatry Psychiatr Epidemiol. 2013;48(8):1289–95. Guan NC, Termorshuizen F, Laan W, Smeets HM, Zainal NZ, Kahn RS, De Wit NJ, Boks MP. Cancer mortality in patients with psychiatric diagnoses: a higher hazard of cancer death does not lead to a higher cumulative risk of dying from cancer. Soc Psychiatry Psychiatr Epidemiol. 2013;48(8):1289–95.
32.
go back to reference Ishikawa H, Yasunaga H, Matsui H, Fushimi K, Kawakami N. Differences in cancer stage, treatment and in-hospital mortality between patients with and without schizophrenia: retrospective matched-pair cohort study. Br J Psychiatry. 2016;208(3):239–44.CrossRefPubMed Ishikawa H, Yasunaga H, Matsui H, Fushimi K, Kawakami N. Differences in cancer stage, treatment and in-hospital mortality between patients with and without schizophrenia: retrospective matched-pair cohort study. Br J Psychiatry. 2016;208(3):239–44.CrossRefPubMed
33.
go back to reference Kisely S, Crowe E, Lawrence D. Cancer-related mortality in people with mental illness. JAMA Psychiat. 2013;70(2):209–17.CrossRef Kisely S, Crowe E, Lawrence D. Cancer-related mortality in people with mental illness. JAMA Psychiat. 2013;70(2):209–17.CrossRef
34.
go back to reference O’Rourke RW, Diggs BS, Spight DH, Robinson J, Elder KA, Andrus J, Thomas CR, Hunter JG, Jobe BA. Psychiatric illness delays diagnosis of esophageal cancer. Dis Esophagus. 2008;21(5):416–21.CrossRefPubMedPubMedCentral O’Rourke RW, Diggs BS, Spight DH, Robinson J, Elder KA, Andrus J, Thomas CR, Hunter JG, Jobe BA. Psychiatric illness delays diagnosis of esophageal cancer. Dis Esophagus. 2008;21(5):416–21.CrossRefPubMedPubMedCentral
35.
go back to reference Chang CK, Hayes RD, Broadbent MT, Hotopf M, Davies E, Møller H, Stewart R. A cohort study on mental disorders, stage of cancer at diagnosis and subsequent survival. BMJ Open. 2014;4(1):e004295. Chang CK, Hayes RD, Broadbent MT, Hotopf M, Davies E, Møller H, Stewart R. A cohort study on mental disorders, stage of cancer at diagnosis and subsequent survival. BMJ Open. 2014;4(1):e004295.
36.
go back to reference He W, Fang F, Varnum C, Eriksson M, Hall P, Czene K. Predictors of discontinuation of adjuvant hormone therapy in patients with breast cancer. J Clin Oncol. 2015;33(20):2262–9.CrossRefPubMed He W, Fang F, Varnum C, Eriksson M, Hall P, Czene K. Predictors of discontinuation of adjuvant hormone therapy in patients with breast cancer. J Clin Oncol. 2015;33(20):2262–9.CrossRefPubMed
37.
go back to reference Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, Henrichs M, Carnicke CLM. The prevalence of psychiatric-disorders among cancer-patients. JAMA. 1983;249(6):751–7.CrossRefPubMed Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, Henrichs M, Carnicke CLM. The prevalence of psychiatric-disorders among cancer-patients. JAMA. 1983;249(6):751–7.CrossRefPubMed
Metadata
Title
Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study
Authors
Huan Song
Fang Fang
Unnur Valdimarsdóttir
Donghao Lu
Therese M.-L. Andersson
Christina Hultman
Weimin Ye
Lars Lundell
Jan Johansson
Magnus Nilsson
Mats Lindblad
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2017
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-016-3013-7

Other articles of this Issue 1/2017

BMC Cancer 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine